Multiple Myeloma: Cancer that took away Bishop Allan Kiuna's life

The late Bishop Allan Kiuna [JCC]

Jubilee Christian Church (JJC) founder Bishop Allan Kiuna died on Tuesday, June 9, 2024, after a brave battle with cancer.

The preacher was diagnosed with Multiple Myeloma in 2018 and immediately began treatment, even going abroad for chemotherapy.

At the time, his wife Rev Kathy Kiuna detailed his progress and in late 2023, Bishop Kiuna was back home, announcing he was free from the chains of cancer.

So, what is Multiple Myeloma?

Multiple myeloma is a type of blood cancer that affects plasma cells, a specialised white blood cell responsible for producing antibodies. This cancer originates in the bone marrow, where plasma cells are made, and can lead to a variety of complications if left untreated.


Symptoms of multiple myeloma can vary but often include bone pain, fatigue, nausea, confusion, and frequent infections. As the disease progresses, it can cause high calcium levels in the blood, kidney problems, and bone fractures. Diagnosis typically involves blood and urine tests, as well as a bone marrow biopsy to detect the presence of abnormal plasma cells.

Causes and risk factors 

The exact cause of multiple myeloma is unknown, but risk factors include obesity, radiation exposure, family history, and certain occupational exposures.  Myeloma is more common in older adults, with the average age of diagnosis around 60 years old. It is also more prevalent in men and African Americans.

Treatment options

Treatment for multiple myeloma aims to manage the disease, alleviate symptoms, and prevent complications. Depending on the stage and risk level of the cancer, options may include chemotherapy, stem cell transplantation, targeted therapies, immunotherapy, and radiation therapy. In some cases, close monitoring without immediate treatment may be the initial approach.

The late Bishop Allan Kiuna. [JCC]

While multiple myeloma is not currently curable, advancements in medical care have significantly improved survival rates in recent years. The five-year survival rate in the United States is now around 54 per cent, and the average life expectancy is approximately six years. Regular check-ups, adherence to treatment plans, and a healthy lifestyle can all contribute to better outcomes for individuals with this condition.

Also read: Chemotherapy took a toll on Bishop Allan Kiuna

It is important to note that multiple myeloma can also lead to the development of other related conditions, such as monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, and amyloidosis. These conditions may require different management strategies, and patients must work closely with their healthcare team to develop the most appropriate treatment plan.


Related Articles